LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rapid COVID-19 Tests Return Minimal False Positives and Moderately High False Negatives, Finds New Study

By LabMedica International staff writers
Posted on 09 Apr 2021
Illustration
Illustration
A new study has found that rapid COVID-19 antigen tests have very low false positive rates but a moderately high false negative rate.

Researchers from the University of Southern California (USC; Los Angeles, CA, USA) conducted the study to see how well inexpensive, easy-to-use COVID-19 tests might work as a screening tool for schools to help them reopen safely. The tests show promise for schools, especially if they use serial testing, such as twice a week.

Children arriving with their parents at a walk-up testing site during the winter surge of COVID cases were given the opportunity to be tested for COVID twice - once with a rapid antigen test and once with the “gold standard” PCR test, to confirm the results of the rapid test. Overall, 774 children ages 5 to 17 years old took both tests. The study found that the rapid antigen tests have very low false positive rates but a moderately high false negative rate. In other words, the tests rarely identified someone as positive who was not but did occasionally identify someone as negative who in fact had COVID.

Among asymptomatic children who had COVID, as measured by the PCR test, the rapid antigen test identified about 50% of COVID-19 cases. The reason the rapid antigen test failed to identify many COVID-19 cases in children was because the majority of children tested had low viral loads as measured by Ct values - the number of times one needs to amplify the test sample to detect the genetic material of the virus. The test was over 90% accurate when focused on the sample of children with high viral loads who were very likely to be infectious. The test was about 99% accurate among asymptomatic children who did not have COVID-19. That is, the test gave a false positive result in one out of 100 asymptomatic children. The researchers suggest that the rapid tests, which require inserting a swab about a half-inch up the nose, could be administered by school staff or be self-administered with supervision. In addition, serial testing could allow schools to relax social distancing rules.

“The good news is that the false negative rate is low in kids likely to be infectious, as measured by viral load,” said Neeraj Sood, who directs the COVID Initiative at the USC Schaeffer Center for Health Policy and Economics. “Serial rapid testing may help compensate for missing the virus in the earliest stage of infection. If you’re testing these kids every four days or every five days, then there’s a good chance that you will catch them when they’re infectious.”

Related Links:
University of Southern California

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more